Gaviscon oralna suspenzija
| Name | Gaviscon oralna suspenzija |
|---|---|
| Marketing Authorisation Number | HR-H-824012801 |
| Active Substance | natrijev alginat natrijev hidrogenkarbonat kalcijev karbonat |
| Composition | 10 ml oralne suspenzije sadrži 500 mg natrijevog alginata, 267 mg natrijevog hidrogenkarbonata i 160 mg kalcijevog karbonata |
| Pharmaceutical Form | oralna suspenzija |
| Manufacturer | RB NL Brands B.V., Schiphol, Nizozemska |
| Marketing Authorisation Holder | Reckitt Benckiser d.o.o., Ulica grada Vukovara 269d, Zagreb, Hrvatska |
| Marketing Authorisation Date | 10.02.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/488 |
| Registration Number | 381-12-01/154-22-10 |
| Prescription | Medicinal product not subject to medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | allowed |
| ATC Code | A02BX13 |
| Marketing status | privremeni prekid opskrbe |
| SmPC | download |
| PL | download |
